Dezhan Healthcare Hits Day Low at CNY 3.25 Amid Price Pressure

Dezhan Healthcare Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 6.84% to touch an intraday low of CNY 3.25. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, Dezhan Healthcare has shown a slight recovery with a 1.24% increase, but its longer-term performance remains concerning. The company has reported a year-to-date decline of 14.84%, and its one-year performance is down by 5.22%. Notably, the stock has underperformed the China Shanghai Composite across various time frames, including the last three years. Financial metrics indicate challenges for Dezhan Healthcare, including a low Return on Capital Employed (ROCE) of 1.63% and a troubling trend in net sales, which have decreased at an annual rate of 10.75% over the past five years. The company has faced negative results for seven consecutive quarters, further highlighting its ongoing difficulties in the market.